仙乐健康上半年归母净利1.61亿元 同比增长4.3%

Core Viewpoint - Xianle Health reported a steady growth in revenue and net profit for the first half of 2025, reflecting a robust adaptation to new consumer trends and a balanced development structure in the Chinese market [1][2]. Financial Performance - The company achieved a revenue of 2.042 billion yuan, representing a year-on-year increase of 2.57% [1]. - The net profit attributable to shareholders was 161 million yuan, up 4.3% year-on-year [1]. - The net profit after deducting non-recurring items was 159 million yuan, with a growth of 3.25% [1]. New Consumer Trends - Xianle Health embraced new consumption trends, with significant breakthroughs in live e-commerce, cross-border e-commerce, private domain, and new retail channels [1]. - Revenue from new consumer clients grew by over 40%, with their contribution to total revenue approaching 50% [1]. Product Development - The company launched 10 major products in the first half of the year and has 25 reserve products in the pipeline, targeting core customer groups such as children, women, and working professionals [2]. - Xianle Health entered the pet nutrition sector, leveraging human technology for pet applications, aiming to create high-end nutritional solutions for pets [2]. Global Expansion - The company achieved breakthroughs in the Americas, Europe, and Asia-Pacific markets, showcasing a "multi-point flowering" strategy [2]. - The European market exceeded sales targets with double-digit growth, adding two new clients with sales exceeding one million euros and establishing a sales entity in the UK [2]. Innovation and Patents - As of June 30, the company held 159 patents, including 94 invention patents, and had 112 health food registration certificates [3]. - Xianle Health actively participated in international industry events to strengthen its technical benchmark position among global B-end clients [3]. Future Strategy - The company plans to leverage its "technology + manufacturing + globalization" advantages to continuously release long-term value during industrial upgrades [3]. - Xianle Health aims to define the global competitiveness of Chinese enterprises through practical actions and innovation [3].